The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute
Issue link: https://lifescienceleadermag.epubxp.com/i/183480
2013 CMO Leadership Awards Winner Profiles DRUG TYPE: Pharmaceuticals Recipharm AB Jordbro, Sweden Manufacturing locations: France, Germany, Spain, Sweden, and U.K. www.recipharm.com 0046 8 6025200 Contact: Kenth Berg info@recipharm.com DRUG LIFE CYCLE STAGES: Research & Development — preclinical and clinical (phase 1, phase 2, and phase 3); Formulated Drug Production — dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, capsules, cartridges, controlled substances, creams & ointments, cytotoxic & high-potency compounds, gels, generics, injectables, liquids, lyophilized products, nonsterile, OTC, parenterals (small volume), powders (nonsterile), semisolids, solid dose, solutions & suspensions, sterile, sustained release, and topicals. ÒI am very pleased that Recipharm has once again won a CMO Leadership Award and particularly in the innovation category. I like to believe that the way we combine our pharmaceutical development expertise with our broad commercial manufacturing capabilities provides our customers with not only a cost-effective and reliable service, but also something which adds true value to their ideas. Customers consistently tell us that this is what they are looking for.Ó Ñ Thomas Eldered, CEO DRUG TYPE: Pharmaceuticals SAI Life Sciences Ltd Hyderabad, A.P., India Manufacturing locations: Hyderabad and Karnataka, India www.sailife.com +91 40 6677 7555 Contact: Marcel Velterop marcel.v@sailife.com DRUG LIFE CYCLE STAGES: Research & Development — discovery, preclinical, clinical (phase 1, phase 2, and phase 3); Drug Substance Production — primary process development and drug substance production; Formulated Drug Production — dosage form development ÒSAI is honored to have been recognized by many of its existing customers for its performance and reliability of the services provided. We have a very strong focus on delivery of services, sometimes requiring efforts beyond the call of duty. We also realize that we still have a way to go to achieve complete customer satisfaction in all cases, and we see this award as a strong encouragement that we are on the right track. We thank all our customers for their feedback and look forward to more.Ó Ñ Krishna Kanumuri, CEO Samsung BioLogics Incheon, South Korea Manufacturing locations: Incheon, South Korea www.samsungbiologics.com 82 2 2255 8505 DRUG TYPE: Biopharmaceuticals Contact: Jeremy Caudill biologics@samsung.com DRUG LIFE CYCLE STAGES: Research & Development — preclinical and clinical (phase 1, phase 2, and phase 3); Drug Substance Production — primary process development, drug substance production; Formulated Drug Production — dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, cartridges, injectables, liquids, lyophilized products, parenterals (large volume), parenterals (small volume), proteins, sterile, and syringes (prefilled). ÒWe are honored to be recognized by our clients as a global biopharmaceutical manufacturing leader for productivity. Samsung BioLogics takes pride in delivering best-in-class manufacturing services, with the highest global quality standards, to our clients. Our success is possible thanks to our highly experienced employees, that consistently demonstrate their commitment to execution excellence. We accept this award as a testament to the dedication and hard work of many within Samsung BioLogics.Ó Ñ Jeremy Caudill, vice president of business development 44 The CMO Leadership Awards 2013